Loomis Sayles & CO L P Tandem Diabetes Care Inc Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$14.28 - $31.03 $5,712 - $12,412	400 New	400 $12,000
Q2 2023 Aug 11, 2023	BUY	$24.18 - $42.46 $1,910 - $3,354	79 New	79 $2,000
Q2 2022 Aug 05, 2022	SELL	$53.22 - $123.09 $159 - $369	-3 Reduced 14.29%	18 $1,000
Q1 2022 May 13, 2022	BUY	$101.89 - $150.09 $2,139 - $3,151	21 New	21 $2,000
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $9,509 - $12,207	-117 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $10,108 - $14,244	117 New	117 $11,000

359

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.